Nonprofit · EIN 52-1752653
CARDIOVASCULAR RESEARCH FOUNDATION
Tax-exempt · NEW YORK, NY 10019
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $68,904,326 | $66,655,898 | $2,248,428 | $87,491,417 | $37,248,809 | $50,242,608 |
| December 31, 2023 | 990 | $78,271,229 | $64,971,760 | $13,299,469 | $91,969,884 | $45,544,170 | $46,425,714 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $7,422,106
- Program service revenue
- $59,958,634
- Investment income
- $1,650,798
- Net gain from sales of assets
- $76,393
- Net income from fundraising events
- -$129,212
- Other revenue
- -$127,212
Expenses
- Grants and similar amounts paid
- $1,000,000
- Compensation of officers, directors and key employees
- $2,026,463
- Other salaries and wages
- $20,987,745
- Salaries, compensation and benefits (total)
- $26,821,269
- Professional fundraising fees
- $0
- Legal fees
- $168,507
- Accounting fees
- $187,322
- Occupancy
- $3,395,472
- Travel
- $1,595,556
- Depreciation
- $997,697
- Program services (functional)
- $58,342,063
- Management and general (functional)
- $8,270,801
- Fundraising (functional)
- $43,034
Balance sheet and other
- Total assets, start of year
- $91,969,884
- Total assets, end of year
- $87,491,417
- Total liabilities, end of year
- $37,248,809
- Net assets, end of year
- $50,242,608
- Land, buildings and equipment
- $7,899,066
- Publicly traded securities
- $24,355,014
- Net assets without donor restrictions
- $50,242,608
- Gross receipts
- $79,177,393
- Employees
- 213
- Volunteers
- 10
- Year formed
- 1991
- State of legal domicile
- DC
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JUAN F GRANADA MD | CEO & DIRECTOR Trustee or director, Officer | 37.5 | $933,460 | $69,098 |
| DAVID COHEN | DIRECTOR OF CLINICAL & OUT Highest-paid employee | 37.5 | $700,158 | $36,515 |
| EILEEN MORALES | CFO Officer | 37.5 | $474,963 | $38,684 |
| DONALD L ABRAMS | CHIEF LEGAL OFFICER Officer | 37.5 | $482,912 | $27,346 |
| ALEXANDRA POPMA | DIRECTOR Highest-paid employee | 37.5 | $461,897 | $23,000 |
| TRICIA RAWH | EXECUTIVE DIRECTOR, CED Highest-paid employee | 37.5 | $431,480 | $23,012 |
| GRZEGORZ KALUZA | DIRECTOR RESEARCH Highest-paid employee | 37.5 | $325,318 | $66,884 |
| DANIEL BURKOFF | DIRECTOR OF HEART FAILURE Highest-paid employee | 37.5 | $315,075 | $56,665 |
| COLETTE Y GARDNER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ERIC B WOLDENBERG | CHAIRMAN Trustee or director, Officer | 2 | $0 | $0 |
| FRANK LITVACK MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JEFFREY W MOSES MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JOSEPH G BECK | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KAREN G KRASNEY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MARTIN B LEON MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
3 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| MARVIN L WOODALL | DIRECTOR Trustee or director | 2 | $0 |
| TERESA LESTE | DIRECTOR Trustee or director | 2 | $0 |
| WILLIAM A HIMMELSBACH | DIRECTOR Trustee or director | 2 | $0 |
990 for the year ended December 31, 2023: 18 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JUAN F GRANADA MD | CEO & DIRECTOR Trustee or director, Officer | 37.5 | $945,463 | $72,139 |
| DAVID COHEN | DIRECTOR OF CLINICAL & OUT Highest-paid employee | 37.5 | $704,590 | $30,000 |
| DONALD L ABRAMS | CHIEF LEGAL OFFICER Officer | 37.5 | $471,379 | $25,997 |
| EILEEN MORALES | CFO Officer | 37.5 | $450,290 | $38,225 |
| ALEXANDRA POPMA | DIRECTOR Highest-paid employee | 37.5 | $437,422 | $0 |
| TRICIA RAWH | EXECUTIVE DIRECTOR, CED Highest-paid employee | 37.5 | $406,000 | $22,512 |
| GRZEGORZ KALUZA | DIRECTOR RESEARCH Highest-paid employee | 37.5 | $314,867 | $66,848 |
| DANIEL BURKOFF | DIRECTOR OF HEART FAILURE Highest-paid employee | 37.5 | $316,055 | $56,556 |
| ERIC B WOLDENBERG | CHAIRMAN Trustee or director, Officer | 2 | $0 | $0 |
| JOSEPH G BECK | DIRECTOR Trustee or director | 2 | $0 | $0 |
| COLETTE Y GARDNER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| WILLIAM A HIMMELSBACH | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JEFFREY W MOSES MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| TERESA LESTE | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ERIC A ROSE MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MARVIN L WOODALL | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KAREN G KRASNEY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| FRANK LITVACK MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 1700 BROADWAY 9TH FLOOR, NEW YORK, NY 10019-6231
- In care of
- % EILEEN MORALES
- Principal officer (990 for 2024)
- JUAN FGRANADA MD, 1700 BROADWAY, NEW YORK, NY 10019
- Signed the 990
- EILEEN MORALES, TREASURER & CFO
- Phone
- (646) 434-4691
- Website
- WWW.CRF.ORG
- Return prepared by
- COHNREZNICK ADVISORY LLC
Mission
TO HELP DOCTORS IMPROVE THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE SUFFERING FROM HEART AND VASCULAR DISEASE THROUGH INNOVATION, INVESTIGATION AND EDUCATION.
Program accomplishments
- CLINICAL TRIALS CENTER - A DISTINGUISHED ACADEMIC RESEARCH ORGANIZATION, THE CRF CLINICAL TRIALS CENTER (CTC) PLANS AND EXECUTES CLINICAL INVESTIGATIONS FROM FIRST-IN-MAN STUDIES TO LARGE, MULTICENTER INTERNATIONAL TRIALS DESIGNED TO GAIN INSIGHTS THAT WILL ELEVATE THE QUALITY OF CARE IN CARDIOVASCULAR MEDICINE. THE CTC SPECIALIZES IN TRIAL DESIGN, EVENT ADJUDICATION, DATA AND SAFETY MONITORING, AND BIO STATISTICAL SERVICES. CRF FACULTY AUTHOR OVER 300 ARTICLES ANNUALLY IN PRESTIGIOUS MEDICAL AND SCIENTIFIC JOURNALS, BRINGING THE LATEST RESEARCH TO THE GLOBAL MEDICAL COMMUNITY.Expenses $19,084,666 · grants $370,000 · revenue $25,769,626
- SKIRBALL CENTER FOR INNOVATION - A STATE OF THE ART INNOVATION CENTER, THE CRF SKIRBALL CENTER FOR INNOVATION IS DEDICATED TO THE INVESTIGATION AND VALIDATION OF NOVEL CONCEPTS, TREATMENTS, AND DEVICES. OUR PREEMINENT TEAM OF PIONEERING RESEARCHERS AND THOUGHT LEADERS CONTINUALLY BREAK NEW GROUND AS THEY GUIDE EARLY IDEAS AND INVENTIONS THROUGH COMPREHENSIVE PRECLINICAL RESEARCH PROGRAMS TO INTRODUCE PRACTICAL THERAPIES INTO CLINICAL MEDICINE.Expenses $6,285,209 · grants $190,000 · revenue $7,560,409
- TCT 2024 (TRANSCATHETER CARDIOVASCULAR THERAPEUTICS) MEETING - THE CARDIOVASCULAR RESEARCH FOUNDATION (CRF) STANDS AT THE FOREFRONT OF EDUCATION IN CARDIOVASCULAR MEDICINE. THIS FOCUS REFLECTS THE CRF FACULTY'S COMMITMENT TO SHARING AND DISSEMINATING THE LATEST CLINICAL RESEARCH INFORMATION TO THE BROADEST AUDIENCE AT THE EARLIEST POSSIBLE DATE. THE FUNDAMENTAL GOAL OF CRF'S EDUCATION PROGRAM IS TO ENABLE THE GLOBAL PHYSICIAN COMMUNITY TO APPLY IMPORTANT NEW KNOWLEDGE TO ACTUAL PATIENT CARE. CRF'S PRINCIPAL ANNUAL EDUCATIONAL EVENT, TRANSCATHETER CARDIOVASCULAR THERAPEUTICS (TCT) MEETING, IS THE WORLD'S LARGEST EDUCATIONAL MEETING DEDICATED TO THE FIELD OF INTERVENTIONAL VASCULAR THERAPY. THIS IS THE SHOWCASE EDUCATIONAL EVENT IN THE CARDIOVASCULAR FIELD AND IS USED TO EDUCATE AND EXCHANGE STUDY FINDINGS AND TO IMPROVE TREATMENT OF PATIENTS WHO HAVE CARDIOVASCULAR DISEASE.Expenses $10,835,512 · grants $307,500 · revenue $17,901,710
- OTHER - INCLUDES WEB SERVICES, OTHER SMALL MEETINGS, AND SUPPORT FUNCTIONS TO EACH OF THE DIVISIONS ABOVE.Expenses $22,136,676 · grants $132,500 · revenue $8,728,889
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 52-1752653
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (509(a)(2))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1992
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H20Z)
- Assets (IRS master file)
- $87,491,417
- Income (IRS master file)
- $79,177,393
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $68,904,326 | $66,655,898 | $87,491,417 | IRS |
| 990 | December 2023 | $78,271,229 | $64,971,760 | $91,969,884 | XML |
| 990 | December 2022 | $61,324,834 | $57,291,678 | $76,093,334 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 52-1752653).
Questions about CARDIOVASCULAR RESEARCH FOUNDATION
- What is the EIN of CARDIOVASCULAR RESEARCH FOUNDATION?
- The employer identification number (EIN) of CARDIOVASCULAR RESEARCH FOUNDATION is 52-1752653.
- Is CARDIOVASCULAR RESEARCH FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1992.
- Are donations to CARDIOVASCULAR RESEARCH FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does CARDIOVASCULAR RESEARCH FOUNDATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of CARDIOVASCULAR RESEARCH FOUNDATION due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did CARDIOVASCULAR RESEARCH FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of CARDIOVASCULAR RESEARCH FOUNDATION?
- The 990 for the year ended December 31, 2024 names JUAN FGRANADA MD.
- Who are the officers and directors of CARDIOVASCULAR RESEARCH FOUNDATION?
- The 990 for the year ended December 31, 2024 lists 18 people; 8 received compensation from the organization, the highest $933,460 (JUAN F GRANADA MD, CEO & DIRECTOR).
- How much revenue does CARDIOVASCULAR RESEARCH FOUNDATION have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $68,904,326, expenses of $66,655,898 and total assets of $87,491,417 at year end.
Other nonprofits in NEW YORK
- MICHAEL J FOX FOUNDATION FOR PARKINSONS RESEARCH EIN 13-4141945 · last filed 990 for 2025
- PUBLIC HEALTH SOLUTIONS EIN 13-5669201 · last filed 990 for 2025
- PARKINSONS FOUNDATION INC EIN 13-1866796 · last filed 990 for 2025
- LICR FUND INC EIN 13-3573053 · last filed 990 for 2024
- GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC EIN 13-4128413 · last filed 990 for 2024
- INTERNATIONAL BRAIN RESEARCH ORGANIZATION EIN 88-4372025 · last filed 990 for 2024
- CANCER RESEARCH INSTITUTE INC EIN 13-1837442 · last filed 990 for 2025
- THE FOUNDATION FOR AIDS RESEARCH EIN 13-3163817 · last filed 990 for 2025